This list of affiliated investigators can help you identify potential research mentors at the University of Pittsburgh. PSTP students can, and do, work with mentors not on this list, but the investigators featured below have expressed interest in hosting PSTP students in their laboratories.
Sameer Agnihotri, PhD
The Brain Tumor Biology and Therapy Laboratory studies pediatric and adult high-grade gliomas (HGG)—focusing on brain tumor signing, glioma metabolism and using genomics to identify novel and effective therapies.
Christopher Bakkenist, PhD
Identify phosphorylations, dephosphorylations and acetylations that regulate ATM activity in vivo
Kara Bernstein, PhD
Repair of DNA damage is crucial to prevent mutations observed in cancer. Using live cell imaging, we study how double-strand breaks are repaired.
Robert Binder, PhD
The mechanisms of cross-priming of antigens during immune responses to cancer, viruses and autoimmunity
Ronald Buckanovich, MD, PhD
Tumor microenvironment, Cancer stem cells, novel therapeutics for cancer
Timothy F. Burns, MD, PhD
Development of targeted therapies for KRAS mutant NSCLC; Reactivation of OIS and apoptosis; Mechanisms of acquired resistance to targeted agents
Yuan Chang, MD
The study of human tumor viruses
Lan Coffman, MD, PhD
Stomal Interactions critical to the survival, growth, and spread of ovarian cancer
Greg Delgoffe, PhD
The metabolic regulation of T cell function, with a specific focus of those T cells that infiltrate the nutrient-poor tumor microenvironment
Umamahefwar Duvvuri, MD, PhD
The molecular landscape of head and neck cancers; Tying this to technical innovations that improve surgical care for these patients
Robert Ferris, MD, PhD
Mechanisms of immune escape and clinical translation to therapeutic cancer immunotherapy trials
Deborah Galson, PhD
Roles of signal transduction pathways, transcription factors, and chromatin epigenetics in pathological changes in osteoclasts and osteoblasts in cancer-induced bone disease and Paget’s disease of bone
Adrian Lee, PhD
Molecular profiling (genomic, transcriptomic, proteomic) of women’s cancers, mouse modeling, and predictive biomarkers for targeted therapy
The Lohmueller lab works on developing genetic engineering approaches to augment adoptive cell therapy (ACT) for the treatment of cancer.
Linda McAllister-Lucas, MD, PhD
Mechanisms by which dysregulated intracellular signaling promotes inflammation and neoplasia
Patrick S. Moore, MD, MPH
The study of human tumor viruses
Steffi Oesterreich, PhD
Hormone response and treatment resistance in breast and ovarian cancer, including the analysis of aberrant genetic and epigenetic changes
Edward Prochownik, MD, PhD
Metabolic, molecular and biochemical changes in animal models of pediatric and adult liver cancers and how best to capitalize on these for therapeutic purposes
Saumendra Sarkar, PhD
Two related aspects involved in interferon production in the context of infectious disease and cancer: Modulation of IFN induction during RNA and DNA virus infections; Mechanisms and consequences of interferon induction in specific tumors
Kathy Shair, PhD
Studying Epstein-Barr virus molecular pathogenesis in the nasopharynx using 3-D cell air-liquid interface culture models.
Richard Steinman, MD, PhD
Mechanisms of white blood cell differentiation & its inhibition in leukemias; Mechanisms of stem cell differentiation & growth control
Anda Vlad, MD, PhD
The Vlad lab focuses on the development of new combination therapies for ovarian cancer and identification of new mechanisms of treatment response or resistance.